Alternatives to Bramante

AI-native drug discovery company pairing 20+ petabytes of cellular data with human genetics to find causal disease targets

Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.

Cellbyte gives pharma Pricing & Market Access teams source-linked HTA and pricing answers in minutes, not weeks.

Cellino's AI-guided optical bioprocessing platform brings patient-specific cell therapy manufacturing to the hospital.

AI-native pharma company using autonomous agents to find new uses for existing drugs and predict patient drug response

Frekils is AI agents for real-world evidence studies — cohorts, SAPs and publication-ready statistics on your own clinical data.

AI drug discovery driven by a wet-and-dry lab-in-the-loop that runs millions of weekly cell experiments.

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Nanograb designs peptide-LNP targeting systems with biophysics-informed AI so genetic medicines reach a chosen cell type instead of the

Physics-based molecular simulation and AI for drug discovery and materials design.

SciSpace BioMed Agent runs multi-omics, variant prioritization, and drug repurposing analysis from plain-language biomedical prompts.

Cloud R&D platform combining ELN, LIMS, automation, and agent-driven Science Foundries for biotech.

BenevolentAI applies a decade-built biomedical knowledge graph to drug target discovery and repurposing for biopharma R&D teams.

Owkin pairs K Pro, an autonomous AI scientist, with 25 million patients' data across 840 hospitals and wet lab validation for drug R&D

Dotmatics pairs an agentic scientific intelligence platform with Luma Agent for governed R&D data analysis.

AI clinical analytics layer that automates data cleaning, medical coding, and statistical submission for pharma sponsors and CROs.

AI protein engineering platform that designs optimized variant plates and learns from every wet-lab round.

NovaFlow is an AI data analyst for biology labs that turns raw sequencing output into cited, publication-ready results.

Harbor turns your protocol PDF into a clinical trial EDC build with AI-powered data capture and monitoring

Delineate assembles clinical pharmacology evidence into MBMA databases and models for dose optimization and go/no-go decisions.

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Open-source Python framework that assembles causal and mechanistic models from literature and biological databases.

BEKhealth reads structured and unstructured EHR data to match patients to trial protocols and to generate research-ready real-world data.

Oncology real-world evidence built from point-of-care data, with AI-driven insights across a global database of six million+ patients.

Iktos pairs generative AI for small-molecule design with AI retrosynthesis and an autonomous robotic DMTA lab.

Automated cloud lab for protein validation — binding, expression and thermostability assays with data back in as little as 3 days

HealthKey uses AI patient identification to scan your EHR daily and surface trial-eligible patients for clinical research.

Haplotype Labs builds SaaS and community tooling for population genetics, aiming to cut sequencing costs 50–90% and speed polygenic risk modeling.

AI-CRISPR target discovery platform pairing AlgenCRISPR gene modulation with the AlgenBrain foundation model for causal immunology and

Clinician-centered clinical trial matching that notifies your patients when a local, medically relevant study exists.